Opko Health, Inc. (NASDAQ:OPK)
Opko Health, Inc. (NASDAQ:OPK) represented a move of -6.88 percent or $0.23 per share and closed its previous day trading session at $3.25. 6.06 Million Shares were traded in the last trading session with an Average Volume of 5.38 Million Shares. The stock currently has a Market Capitalization of 1.77 Billion.
OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.
The stock traded between $2.66 and $6.40 over 1-Year time period showing its price to sales ratio of 1.84. Opko Health, Inc. (NASDAQ:OPK) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-8.1 and 200-Day Simple Moving Average of $-21.31. Its Price to Free Cash Flow is 0 and Price to Book of 1.02.
Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Opko Health, Inc. (NASDAQ:OPK) reported its Actual EPS of $-0.05/share. The analysts offering Earnings Estimates for the company were believing that Opko Health, Inc. could bring EPS of $-0.08/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 37.5 Percent.
Cronos Group Inc. (NASDAQ:CRON)
In the last trading session, Cronos Group Inc. (NASDAQ:CRON) added its value by -2.7% closing at the price of $10.45. The stock currently has market capitalization of 1.85 Billion, with average volume of 17.12 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Cronos Group Inc. (NASDAQ:CRON) is showing beta of 0. This particular value of beta suggests that Cronos Group Inc. (NASDAQ:CRON) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Cronos Group Inc. (NASDAQ:CRON) is at $-0.03.
The stock currently has RSI of 63.09. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.
Cronos Group Inc. (NASDAQ:CRON) topped its 52-week high price of $15.30 on 09/19/18 and 52-Week Low Price of $ 3.31 on 12/08/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 13.97% and monthly volatility of 10.56% respectively.